Invivyd, Inc. (NASDAQ:IVVD) Sees Large Growth in Short Interest

Invivyd, Inc. (NASDAQ:IVVD) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 8,260,000 shares, an increase of 24.0% from the March 15th total of 6,660,000 shares. Based on an average trading volume of 14,600,000 shares, the short-interest ratio is currently 0.6 days. Approximately 10.9% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

IVVD has been the subject of a number of research reports. HC Wainwright reissued a “buy” rating and set a $10.00 price objective on shares of Invivyd in a research report on Wednesday, March 26th. D. Boral Capital restated a “buy” rating and issued a $9.00 price objective on shares of Invivyd in a report on Thursday, March 20th.

Institutional Trading of Invivyd

Several large investors have recently modified their holdings of IVVD. Jane Street Group LLC boosted its holdings in Invivyd by 290.5% during the fourth quarter. Jane Street Group LLC now owns 117,432 shares of the company’s stock valued at $52,000 after acquiring an additional 87,358 shares during the period. Barclays PLC grew its holdings in Invivyd by 179.6% in the 3rd quarter. Barclays PLC now owns 117,973 shares of the company’s stock valued at $120,000 after buying an additional 75,780 shares during the last quarter. Renaissance Technologies LLC bought a new position in Invivyd in the 4th quarter worth approximately $74,000. JPMorgan Chase & Co. lifted its holdings in shares of Invivyd by 644.1% during the fourth quarter. JPMorgan Chase & Co. now owns 256,900 shares of the company’s stock worth $114,000 after buying an additional 222,375 shares during the last quarter. Finally, Two Sigma Advisers LP grew its stake in shares of Invivyd by 1,276.5% in the fourth quarter. Two Sigma Advisers LP now owns 304,200 shares of the company’s stock worth $135,000 after acquiring an additional 282,100 shares during the last quarter. 70.36% of the stock is owned by institutional investors.

Invivyd Trading Up 10.0 %

Invivyd stock traded up $0.05 during mid-day trading on Monday, hitting $0.56. 2,616,328 shares of the company’s stock were exchanged, compared to its average volume of 4,277,600. Invivyd has a 1-year low of $0.35 and a 1-year high of $2.74. The stock has a 50 day moving average of $0.87 and a two-hundred day moving average of $0.79. The stock has a market cap of $67.30 million, a P/E ratio of -0.29 and a beta of 0.41.

Invivyd (NASDAQ:IVVD) last issued its quarterly earnings data on Thursday, March 20th. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.10. The company had revenue of $13.80 million during the quarter, compared to the consensus estimate of $13.57 million. As a group, research analysts predict that Invivyd will post -1.64 EPS for the current fiscal year.

Invivyd Company Profile

Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering.